Michael Egholm
CIK 1559779 · View on SEC EDGAR ↗
First SEC filing: April 6, 2022 · Latest: April 6, 2022
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | LAB | S | 5,473 | $0.94 | $5,145 | 2,741,191 Direct | -0.20% | Disposed | -26.7% (price as of 2026-08-18) |
| May 22, 2025 | LAB | S | 5,116 | $1.00 | $5,116 | 2,746,664 Direct | -0.19% | Disposed | -31.1% (price as of 2026-08-18) |
| May 21, 2025 | LAB | S | 4,719 | $1.03 | $4,861 | 2,751,780 Direct | -0.17% | Disposed | -33.1% (price as of 2026-08-18) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 6, 2026 | LAB | Restricted Stock Units | Common Stock (196,513) | — | — | 196,513 | Disposed |
| March 20, 2026 | LAB | Stock Option (Right to buy) | Common Stock (2,345,340) | $0.98 | March 20, 2036 | 2,345,340 | Acquired |
| April 4, 2025 | LAB | Restricted Stock Units | Common Stock (196,512) | — | — | 196,512 | Disposed |
| March 21, 2025 | LAB | Stock Option (Right to buy) | Common Stock (1,782,500) | $1.21 | March 21, 2035 | 1,782,500 | Acquired |
| May 20, 2024 | LAB | Stock Option (Right to Buy) | Common Stock (2,250,000) | $2.58 | May 20, 2034 | 2,250,000 | Acquired |
| April 4, 2024 | LAB | Restricted Stock Units | Common Stock (196,512) | — | — | 196,512 | Disposed |
| April 4, 2023 | LAB | Restricted Stock Units | Common Stock (196,512) | — | — | 196,512 | Disposed |
| April 4, 2022 | LAB | Stock Option (Right to Buy) | Common Stock (4,529,773) | $3.99 | April 4, 2032 | 4,529,773 | Acquired |
| April 4, 2022 | LAB | Restricted Stock Units | Common Stock (786,049) | — | — | 786,049 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| April 6, 2022 | LAB | Common Stock | 5,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
LAB
CEO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $680,256 | — | $5,337,883 | $1,671,363 | $1,120,000 | — | $14,000 | $8,823,502 |
| 2024 | $686,250 | — | — | — | $490,000 | — | $33,308 | $8,337,044 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.